NaV1.7: stress-induced changes in immunoreactivity within magnocellular neurosecretory neurons of the supraoptic nucleus. 2013

Joel A Black, and Janneke G J Hoeijmakers, and Catharina G Faber, and Ingemar S J Merkies, and Stephen G Waxman
Department of Neurology, Yale University School of Medicine, New Haven, CT 06510, USA.

BACKGROUND NaV1.7 is preferentially expressed, at relatively high levels, in peripheral neurons, and is often referred to as a "peripheral" sodium channel, and NaV1.7-specific blockers are under study as potential pain therapeutics which might be expected to have minimal CNS side effects. However, occasional reports of patients with NaV1.7 gain-of-function mutations and apparent hypothalamic dysfunction have appeared. The two sodium channels previously studied within the rat hypothalamic supraoptic nucleus, NaV1.2 and NaV1.6, display up-regulated expression in response to osmotic stress. RESULTS Here we show that NaV1.7 is present within vasopressin-producing neurons and oxytocin-producing neurons within the rat hypothalamus, and demonstrate that the level of Nav1.7 immunoreactivity is increased in these cells in response to osmotic stress. CONCLUSIONS NaV1.7 is present within neurosecretory neurons of rat supraoptic nucleus, where the level of immunoreactivity is dynamic, increasing in response to osmotic stress. Whether NaV1.7 levels are up-regulated within the human hypothalamus in response to environmental factors or stress, and whether NaV1.7 plays a functional role in human hypothalamus, is not yet known. Until these questions are resolved, the present findings suggest the need for careful assessment of hypothalamic function in patients with NaV1.7 mutations, especially when subjected to stress, and for monitoring of hypothalamic function as NaV1.7 blocking agents are studied.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009997 Osmotic Pressure The pressure required to prevent the passage of solvent through a semipermeable membrane that separates a pure solvent from a solution of the solvent and solute or that separates different concentrations of a solution. It is proportional to the osmolality of the solution. Osmotic Shock,Hypertonic Shock,Hypertonic Stress,Hypotonic Shock,Hypotonic Stress,Osmotic Stress,Hypertonic Shocks,Hypertonic Stresses,Hypotonic Shocks,Hypotonic Stresses,Osmotic Pressures,Osmotic Shocks,Osmotic Stresses,Pressure, Osmotic,Pressures, Osmotic,Shock, Hypertonic,Shock, Hypotonic,Shock, Osmotic,Shocks, Hypertonic,Shocks, Hypotonic,Shocks, Osmotic,Stress, Hypertonic,Stress, Hypotonic,Stress, Osmotic,Stresses, Hypertonic,Stresses, Hypotonic,Stresses, Osmotic
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013495 Supraoptic Nucleus Hypothalamic nucleus overlying the beginning of the OPTIC TRACT. Accessory Supraoptic Group,Nucleus Supraopticus,Supraoptic Nucleus of Hypothalamus,Accessory Supraoptic Groups,Group, Accessory Supraoptic,Groups, Accessory Supraoptic,Hypothalamus Supraoptic Nucleus,Nucleus, Supraoptic,Supraoptic Group, Accessory,Supraoptic Groups, Accessory,Supraopticus, Nucleus
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Joel A Black, and Janneke G J Hoeijmakers, and Catharina G Faber, and Ingemar S J Merkies, and Stephen G Waxman
August 1995, Neuroscience letters,
Joel A Black, and Janneke G J Hoeijmakers, and Catharina G Faber, and Ingemar S J Merkies, and Stephen G Waxman
March 2014, Experimental neurology,
Joel A Black, and Janneke G J Hoeijmakers, and Catharina G Faber, and Ingemar S J Merkies, and Stephen G Waxman
November 1992, Brain research,
Joel A Black, and Janneke G J Hoeijmakers, and Catharina G Faber, and Ingemar S J Merkies, and Stephen G Waxman
January 1991, Brain research. Developmental brain research,
Joel A Black, and Janneke G J Hoeijmakers, and Catharina G Faber, and Ingemar S J Merkies, and Stephen G Waxman
November 2004, Endocrinology,
Joel A Black, and Janneke G J Hoeijmakers, and Catharina G Faber, and Ingemar S J Merkies, and Stephen G Waxman
April 2011, Journal of neuroscience methods,
Joel A Black, and Janneke G J Hoeijmakers, and Catharina G Faber, and Ingemar S J Merkies, and Stephen G Waxman
August 1995, The Journal of physiology,
Joel A Black, and Janneke G J Hoeijmakers, and Catharina G Faber, and Ingemar S J Merkies, and Stephen G Waxman
June 2015, Journal of neuroendocrinology,
Joel A Black, and Janneke G J Hoeijmakers, and Catharina G Faber, and Ingemar S J Merkies, and Stephen G Waxman
March 1988, The Journal of physiology,
Joel A Black, and Janneke G J Hoeijmakers, and Catharina G Faber, and Ingemar S J Merkies, and Stephen G Waxman
August 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Copied contents to your clipboard!